(1)
Retention Rate of Tumor Necrosis Factor Inhibitors, Anti-Interleukin 17, and Anti-Interleukin 12 23 Drugs in a Single-Center Cohort of Psoriatic Arthritis Patients. Reumatismo 2023, 75 (2). https://doi.org/10.4081/reumatismo.2023.1544.